The Swedish-British company AstraZeneca has changed the name of its coronavirus vaccine to Vaxzevria.
This has been reported on the website of the Swedish Medical Products Agency, adding that changing the name of the vaccine will not change any of the drug characteristics. The only difference is the labeling and packaging of medicines.
At the same time, the reasons for the renaming of the vaccine has not been specified.
Context. In March, more than 20 countries suspended the use of the Swedish-British vaccine AstraZeneca after several dozen cases of thrombosis and thromboembolism had been detected. Later, two independent groups of scientists in Germany and Norway found that the AstraZeneca vaccine can lead to a decrease in blood clotting in the brain blood vessels. However, WHO experts did not find evidence of a link between thromboembolism and the drug.
Last week, it became known about the death of a servicewoman in the Odesa region, who was vaccinated against the coronavirus with the AstraZeneca vaccine—Covishield.